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Summary
We examined if suppressor cell clones may be established from adult bone marrow that contains
a populationofcellscapable of specifically downregulating the immune response directed toward
self-major histocompatibility complex (MHC) antigens. Freshly prepared adult C3H (H-2k)
marrow cells were cultured in medium containing interleukin 2 (IIr2), Ilr3, or a mixture of
IIr2 and IIr3. After 7-10 d, cells grown in Ilr3-containing medium were screened for theircapacity
to suppress cytotoxic T lymphocyte (CTL) generation against self-MHC antigens in allogeneic
mixed lymphocyte cultures. Cells capable of suppressing anti-OH CTL generation were cloned
by limiting dilution. Several suppressor clones were established that exhibited strong suppression
of anti-H-2k, anti-H-2Kk/Ik, and anti-H-21)k CTL generation, but failed to suppress anti-H-2d
and anti-H-2b responses. When tested in a skin allograft model, intravenous injections of these
bone marrow-derived anti-self suppressor cells (2.5 x 107 cells) together with I1r3 induced
prolongation of C3H skin allografts in anti-mouse lymphocyte serum-treated B6AFi mice.
Injection of 11,3 alone had no effect on allograft survival. Moreover, these cells failed to prolong
B10AKM skin allografts on B6AFt recipients. Northern blot analysis showed that these cells
express full-length transcripts of the T cell receptor (TCR) y gene, but not those of TCR u,
(3, or S genes. However, no rearrangement of y gene was observed by Southern blot analysis.
Flow cytometric analysis revealed that bone marrow-derived suppressor cells are strongly positive
for Thy-1 antigen but negative for CD3, CD4 (L3T4), and CD8 (Lyt-2) surface markers, and
express only class I MHC antigens. Suppressor cells derived from adult bone marrow may play
an important role in extrathymic induction of self-tolerance.
A
dult bone marrow contains a population ofcells capable
of specifically downregulating the immune response
directed toward self-MHC antigens. In a mouse skin allograft
model, significant prolongation of C3H/He (OH) skin al-
lograft survival is induced in immunosuppressed (C57BL/6
x A)F1 (B6AFi) mice by injection of C3H bone marrow
cells postoperatively (day +8 relative to grafting on day 0)
(1). Immunosuppression is achieved by intraperitoneal injec-
tion of rabbit anti-mouse lymphocyte serum (ALS)t given
on days -1 and +2. Graft survival in ALS-treated, donor
bone marrow-injected mice is usually 20-40 d over that in
controls given ALS alone. That injection of unrelated
C57BL/6 bone marrow cells has no effect in prolongingC3H
skin allograft survival on ALS-treated B6AFt recipient mice
(1) illustrates the antigen-specific nature of this bone marrow
cell-induced unresponsiveness. The role of suppressor cells
'Abbreviations used in this paper . ALS, anti-mouse lymphocyte serum;
CTLL, cytotoxic T lymphocyte line; NC, natural cytotoxic.
specific for their own MHC antigens is indicated in this un-
responsive state; adoptive transfer of spleen cells from ALS-
and donor bone marrow-treated B6AFt mice unresponsive
to C3H skin allografts to the secondary ALS-treated B6AFt
recipient mice achieves prolongation of C3H skin allograft
survival but not that of DBA/2 skin graft survival (2). Fur-
ther analysis by in vitro coculture MLC experiments demon-
strated that these putative-suppressor cells bear Thy-1 deter-
minants and MHC antigens of the marrow and skin donor,
suggesting that, these cells are derived from injected donor
bone marrow cells (3).
In an in vitro MLC system, addition offresh bone marrow
cells from normal adult mice or T cell colonies grown from
bone marrow cultures causes suppression of generation of
CTL directed against MHC antigens shared by the stimu-
lator cells and the added cells (4-6). Suppression is thought
to be mediated through prevention of differentiation of CTL
precursors to CTL. Subsequently, cloned CTL were also
shown to suppress CTL generation against their surface MHC
antigens irrespective of the specificity of their receptor for
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against "self" MHC antigens, these cells were called "veto
cells" (10).
In thepresent paper, we report establishmentof suppressor
cell clones by culturing adult bone marrow cells in IL3. These
bone marrow-derived clones are strictly dependent on Ilr3
for their continuous growth, and are capable of inhibiting
in vitro and in vivo cellular immune responses against self-
MHC antigens. These cells express Thy-1 determinants but
lack any other T cell surface markers, such as CD3, CD4,
and CD8 determinants, and TCR proteins. The cells tran-
scribe TCR y gene without 'y gene rearrangement. These
bone marrow-derived cells mayplay an important role in the
induction of self-tolerance.
Materials and Methods
Mice. C3H/He (C3H), C57BL/6, DBA/2, (C57BL/6 x
A)Fj (B6AFt), A, and C3H.OH mice were purchased from The
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Jackson Laboratory, Bar Harbor, ME. Mice were used at 2-7 mo
ofage. B10.MBR mice were kindlyprovidedby Dr. Martin E. Dorf,
Department ofPathology, HarvardMedicalSchool, Boston, MA.
Cytokines.
￿
48-h culturesupernatant ofWEHI-3 cells (WEHI.CS)
was used as a source of IL-3. Purified human IL-2 was purchased
from Electro-Nucleonics, Silver Spring, MD. rIL2 and rIL3 were
purchased from Genzyme, Boston, MA.
Bone Marrow Cell Culture.
￿
Fresh bone marrow cells were ob-
tained from the femurs of adult C3H mice and plated in 24-well
plates (Flow Laboratories, Inc., McLean, VA) at 105 cells/ml/well
in RPMI 1640 containing 10% FCS, 5 x 10-5 M 2-ME, and ei-
ther mouserIL2 (50 U/ml) or purified human11,2 (5 U/ml), IL-3
(WEHI.CS at 25% [vol/vol] or rIL3 at 10 U/ml), or mixtures
of IL2 and IL3 (IL2/3). One half of the culture medium was
replaced twice weekly with fresh medium supplemented with ap-
propriatecytokines. After significant cell growth was obtained, the
surviving cells were split every 4-7 d. When sufficient numbers
ofcellsgrew,cells were assayed for theircapacity to suppress gener-
ation ofCTL in allogeneic MLC. Cells capable ofsuppressing anti-
C3H CTL generation were cloned by limiting dilution . Cloned
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Figure 1.
￿
MHC antigen specificity suppression by I1,3-dependent clones 11.7 and 3.2. 5 x 104 irradiated (2,000 rad) clone 11.7 cells ("---"),
clone 3.2 cells ("---A), or C3H splenocytes (O-O) were added to each 16-mm well containing 5 x 106 responder nylon wool-nonadherent
splenocytes and 105 irradiated stimulator splenic adherent cells. Responder cell-stimulator cell combinations are as indicated above. After a 5-d
culture, surviving cells were assayed at various E/T ratios against 5'Cr-labeled 3-d Con A-stimulated spleen cells. C3H blast targets were used
for C57BL/6 anti-C3H, DBA/2 antiA, and DBA/2 anti-C3H.OH, DBA/2 blasts for C57BL/6 anti-DBA/2 and C3H anti-DBA/2, C57BL/6
blasts for DBA/2 anti-C57BL/6, and B10.MBR blasts for DBA/2 anti-B10.MBR effector cells. Results are expressed as percent specific lysis. (A)
One experiment and (B) two experiments in which suppression of DBA/2 anti-C3H and no suppression of DBA/2 anti-C57BL/6 were always
confirmed (parts of data not shown). Spontaneous release was -20-30% of maximal release in all experiments.
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20 -cells were further propagated in 24-well plates and then assayed
for theircapacity to inhibit allogeneic MLC-induced CTLgenera-
tion. Suppressor clones were maintained in 25-cm' flasks. These
cells were also frozen and stored in liquid nitrogen.
MLCandCytotoxicity Assay.
￿
MLCwasprepared in RPMI 1640
supplemented with 5% FCS, 5 x 10 -5 M 2-ME, and penicillin
(100 U/ml), and streptomycin (100 14g/ml). For screening of sup-
pressor activity, irradiated cloned cells (5 x 103) were added to
both C57BL/6 anti-C3H and C57BL/6 anti-DBA/2 MLC pre-
pared in 96-well U-bottomed plates with 7.5 x 105 responder
splenocytes and 5 x 105 irradiated stimulator splenocytes in a total
volume of 200 ul. After a 5-d incubation, 100 itl of the cell mix-
ture was transferred to a V-bottomed well containing 10" 5tCr-
labeled target cellsin 100 it,l ofmedium. For theassayof specificity
of suppression, 5 x 104 irradiated (2,000 rad) cloned bone marrow
cells were added to a 16-mm well containing 5 x 106 responder
nylon wool-nonadherent splenocytes and 105 irradiated (4,000 rad)
stimulator splenicadherent cells. Irradiated normal splenocytes were
added to control cultures. After a 5-d incubation, surviving cells
were assayed at various E/T ratios against "Cr-labeled targets.
Targets were 3-d Con A blasts of spleen cells. "Cr-release assay
andcalculation ofpercent specific lysiswere done as previously de-
scribed (11).
mAbs.
￿
FITC conjugates of mAbs 30-H12 (antiThy-1.2) and
53-6.7 (anti-CD8), and PE conjugate of mAb GK1.5 (anti-CD4)
were obtained from Becton Dickinson&Co., Mountain View, CA.
Thehamster mAb 145-2C11(anti-CD3-e) was used as culture su-
pernatantandan FITC conjugate.ThehamstermAb 3A10, which
is specific to amurine TCR-S (12),wasused as culture supernatant
and biotin conjugates. This antibody was kindly provided by Dr.
S. Itohara of the Massachusetts Institute of Technology, Boston,
MA. Mouse mAb HB 24 (anti-H-21)k) was used as culture super-
natant. Mouse mAbs 11-4 .1 (anti-H-2Kk) and 11-5.2 (anti-I-A')
were purchased from Becton Dickinson & Co. These antibodies
were stained with FITC-conjugatedgoat anti-mouse IgG(Cappel
Laboratories, Malvern, PA).
Flow Cytometric Analysis.
￿
Single cell suspensions were stained
by the standard procedures. Propidiumiodide (0.5,ug/ml)was used
to eliminatethedeadcellsfrom thedata. Two-colorimmunofluores-
cence analysis for Thy-1, CD3, CD4, CD8, and TCR-y/6 deter-
minants was done at the Department of Biology, Massachusetts
Institute of Technology, by Dr. Itohara. Cells were stained with
FITC-andbiotin-conjugated antibodies and streptavidin-PE(Becton
Dickinson & Co.). Negative controls were incubated with strep-
tavidin-PE andaffinity-purified goat anti-hamster IgG-FITC. Anal-
ysis of these samples, as well as single-color analyses for surface
MHC antigens, wasdone with a single-beam flow cytometer, FAC-
Scan (Becton Dickinson & Co.) and the FACScan Research Soft-
ware (Becton Dickinson & Co.).
Analysis of 1CR Genes by Northern Blot andSouthern Blot Anal-
yses. Totalcellular RNAs were isolated by guanidine isothiocyanate
andcesium chloride (CsCI) gradient centrifugation (13, 14). Con-
centration of RNAin Tris/EDTA buffer was measured at 260-nm
wave length by DU-70spectrophotometer (Beckman Instruments,
Inc., Fullerton, CA). 15 ug of totalRNAs were subjected to elec-
trophoresis on 1% agarose/formaldehyde gels and transferred to
GeneScreenPlus membranes(DuPont, Boston,MA) with 10x SSC.
Membranes were baked at 80°C for 2 h, and prehybridized with
50% deionizedformamide, 1 MNaCl, 1% SDS, and 10% dextran
sulfate for at least 3 h at 42°C. TCR cce, a, and Y chain cDNA
clones, pHDS 12, pHDS 22, and pHDS 4 (15, 16), respectively,
were kindly provided by Dr. H. Saito, Dana Farber Cancer Insti-
tute, Boston, MA. TCR 6chaincDNA clone, KN12D1(17), was
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kindly provided by Dr. Y Takagaki, Massachusetts InstituteofTech-
nology. The cDNA insert was labeled with 31P by the random
primer method (18) and used as a probe. RNA blots were hybrid-
ized in 50% deionized formamide,1 M NaCl, 1% SDS, 10% dex-
tran sulfate, 100 ug/mldenatured salmon spermDNA, andlabeled
cDNA probe (sp act 2-5 x 108 cpm/Wg) at 42°C for overnight.
Afterhybridization, themembranes were washed with afinalstrin-
gencywash for30 min at 60°C in 0.1x SSC, and exposed to x-ray
films.
For Southern blot analysis, genomic DNA was isolated from
the adult C3H mouseliver, cytotoxic T lymphocyte line (CTLL)
cells, or cultured bone marrow cells accordingto the standard pro-
cedure (19). 10 i~g of DNA was digested with EcoRl or HindIII
restriction enzymes (New EnglandBiolabs, Beverly, MA), subjected
to electrophoresis on 0.8% agarose gel, and transferred to Gene-
ScreenPlus membranes. Membranes were dipurinated with 0.25N
HCl and then denaturedwith 0.4 NNaOH and0.6 M NaCl. Pre-
hybridization andhybridization conditions were thesame as those
for Northern blot analysis. All of the cDNA probes were labeled
by therandom primer method. After hybridization, themembranes
were washed andexposedto x-rayfilms as described for Northern
blotting.
Skin Grafting.
￿
Preparation of ALS andskin grafting techniques
have been previously described (1).
Results
In an attempt to study in vitro the differentiation of self-
MHC antigen-specific suppressor cells from bone marrow,
we cultured freshly prepared adult C3H marrow cells in IL
2, WEHI.CS (IL3), or a mixture of IL2 and IL -3 (Hr2/3).
After a 7-10 d incubation, significant cell growth was ob-
served in cultures containing IL3 alone or IL2/3, but not
in cultures containing IL-2 alone. Growingcells were screened
for their capacity to suppress CTL generation against self-
MHC antigens. Cells that suppressed anti-selfCTL genera-
tion were cloned by limiting dilution in IL3-containing
medium. Subcloning and screening for specific suppression
were repeated. Several suppressor cell clones, such as C3H.BM
11.7, BM 11.12, and BM 3.2, were obtained. Fig. 1 illus-
trates alloantigen specificity of suppression mediated by clone
C3H.BM 11.7 (clone 11.7) and BM 3.2 (clone 3.2). Clone
11.7 and 3.2 cells mediated significant suppression of CTL
generation against self-MHC antigens (C57BL/6 anti-OH).
The suppression was on the order of 12-50-fold. There was
no suppression of C57BL/6 anti-DBA/2 response by both
clone 11.7 and3.2 cells. Suppression was either absent or min-
imal (up to twofold) when responder cells were from C3H
mice (C3H anti-DBA/2). Specificity of inhibition with re-
gard to theclass I and class II MHCantigens was examined.
As shown in Fig. 1 B, both clones 11.7 and 3.2 mediated
suppression when they were added to DBA/2 anti-A (anti-
H-2Kk and Ik) and DBA/2 anti-C3H.OH (anti-H-21)k) sen-
sitization cultures. However, when they were added to DBA/2
anti-B10.MBR (anti-H-W' I-Ak, I-Ek and De), no signifi-
cant inhibition was observed. Since C3H andB10.MBR strains
share class II MHC antigens but differ at class I MHC an-
tigens, it appears that suppression was directed towards the
responses against class I self-MHC antigens (anti-self-specific
suppression). Suppression was dependent on the numbers ofcloned cells added. Significant suppression was observed with
a number of cloned cells as few as 1/1,000 of responder cells .
Moreover, significant suppression was observed from day 3
of culture and was not due to the shifting of peak response
(data not shown) .
Natural cytotoxic (NC) cells have been shown to exhibit
suppression of in vitro CTL generation (20-22) . Some of
the suppressor NC cells are IL3 dependent (23) . Therefore,
we examined whether clone 11.7 had NC-like lytic activity.
L929 target cells, which are susceptible to NC cells (22), were
used. Table 1 shows that, in an 18-h 5'Cr-release assay, clone
11.7 cells failed to lyse L929 targets that were susceptible to
lysis by DBA/2 anti-OH splenocytes. Clone 11.7 cells also
failed to lyse YAC-1 targets in a 4-h "Cr-release assay, while
the same targets were lysed byC57BL/6 splenocytes that are
rich in NK cells, as well as by DBA/2 anti-OH splenocytes .
Moreover, electron microscopic analysis showed that the clone
11.7 cells are morphologically lymphoid cells and lack cyto-
plasmic granules that are characteristic of NC cells.
In vivo immunosuppressive capacity of these bone mar-
row-derived anti-self suppressor cells was tested in a skin al-
lograft model . All B6AF 1 recipient mice (H-2bik .d) were
treated withALS on days -1 and +2 relative to skin grafting
on day 0 . In one experiment, a C3H bone marrow-derived
clone (clone 3.2 cells, 2.5 x 10 7 cells) was injected intrave-
nously into B6AFi mice bearing H-2D region-incompatible
Table 1 .
￿
Cytotoxic Activity of Clone 11.7 Cells
NK- and NC-like activities of clone 11.7 were examined on NK-
sensitive (YAC-1) and NC-sensitive (L929) targets . 8-wk-old
C57BL/6 splenocytes and DBA/2 anti-C3H splenocytes were used as
positive controls . Effector cells were incubated for 4 h with YAC-1
and 18 h with L929 target cells . Results are expressed as percent
specific release .
' DBA/2 anti-C3H splenocytes were generated by 5-d mixed lym-
phocyte culture.
4 NC activity of clone 11.7 cells was tested with mouse r-IL-3 (10
U/ml) in the media .
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C3H (H-2Dk) skin grafts starting on day +8 followed by
injection intraperitoneally of 1 ml ofWEHI.CS (equivalent
to -100 U of rIL 3) (Fig. 2 A) . Four injections of cloned
cells and WEHI.CS on postgrafting days 8, 15, 22, and 29
induced significant prolongation of C3H allograft survival .
7 of 10 allografts (70%) survived for > 40 d in mice given
Figure 2 .
￿
In vivo suppressive activity of 11r3-dependent bone
marrow-derived clones . (C57BL/6 x A)F1 (B6AF 1 ) mice were
treated with ALS on days -1 and +2 relative to skin grafting on
day 0 . (A) Two groups of B6AF1 mice bearing C3H skin allografts
were given either one (n = 9) or four (n = 10) weekly injections of
C3H clone 3.2 cells (2 .5 x 10 7 cells intravenously) and 11,3 (1 ml of
WEHI.CS intraperitoneally) starting on day +8 . Control mice re-
ceived ALS alone (n = 19) . (B) Two groups of B6AFt mice bearing
C3H skin allografts were given four week injections of 2 .5 x 10 7
clone 11 .7 cells (n = 8) or C3H clone 3 .2 cells (n = 4) together
with mouse rIL3 (200 U) starting on day +3 . Control mice received
ALS alone (n = 12) or ALS and four weekly IL-3 injections (n =
8) . (C) B6AFt mice bearing B10.AKM skin allografts were given
four weekly injections of rIL3 (200 U) alone (n = 6) or 2 .5 x 107
clone 3 .2 cells together with IL3 (n = 7) starting on day +3 .
Effector
cells
E/T
ratio
Percent specific release
YAC-1 L929
mean ± SEM
C57BL/6 100 :1 13.5 ± 0.7 ND
splenocytes 50 :1 8.4 ± 0.5 ND
25 :1 5.1 ± 0.3 ND
DBA/2 anti-C3H' 100 :1 36.9 ± 1.0 83.2 ± 3.9
splenocytes 50 :1 38.3 ± 2.2 87.8 t 4.9
25:1 28.0 ± 0.8 72 .0 ± 0.8
Clone 11.7 cells 100:1 - 2 .7 ± 0.3 - 4.5 ± 0.64
50 :1 - 3 .4 ± 0.7 - 2.6 ± 2.5
25 :1 - 3.3 ± 0.7 1.7 ± 1.1clone 3.2 cells compared with 3/19 (16%) allografts in ALS
controls . A single injection of cells together with WEHI.CS
on day +8 was less effective . Injection ofWEHI.CS alone
or other nonsuppressive IL-3-dependent cells together with
WEHI.CS, either once or four times according to the same
protocol, failed to prolong graft survival (data not shown) .
In another experiment, clone 11.7 cells or clone 3.2 cells (2.5
x 10 7 cells) were injected intravenously four times (post-
grafting days 3, 10, 17, and 24) together with mouse rIL3
(200 U) intraperitoneally (Fig. 2 B) . All allografts survived
in recipient mice given cloned cells and IL-3 for 340 d, com-
pared with 3 of 12 allografts (25%) in ALS controls or one
of seven allografts (14%) in mice given rIL3 alone four times.
In a separate experiment, clone 3.2 cells (2.5 x 107) were
given four times (postgrafting days 3, 10, 17, and 24) to-
gether with mouse rIL3 (200 U) to B6AFt mice grafted
with B10.AKM (H-2Kk , Ik, D9) skin allografts that differ
from the recipient mice only at the H-2D locus . As shown
in Fig. 2 C, the bone marrow-derived suppressor cells failed
to prolong skin allografts over rIL3 controls. Thus, present
data show that these bone marrow-derived, IL3-dependent
cells are capable of specifically suppressing immune responses
directed against self-MHC antigens expressed on skin al-
lografts.
Cells of the early T cell lineage have been shown to ex-
press TCR cx, /3, y, and S genes (24, 25) . Therefore, TCR
gene transcription of the marrow-derived suppressor clones
was analyzed. Total cytoplasmic RNA was analyzed by
Northern blotting with TCR a (pHDS 12), (3 (pHDS 22),
y (pHDS 4), and S (KN12D1) chain cDNA probes. cDNA
clones pHDS 12, pHDS 22, and pHDS 4 represent J« + C«,
V07 + Cp2, and Cy2 gene segments, respectively . KN12D1
cDNA clone is derived from the Ja1 + Ca gene segment .
Fig. 3A shows that both clone 11.7 and 11.12 cells express
1.5-kb -y-specificRNA, equivalent to full-lengthV+C tran-
scripts ofthey genes . The same blot failed to hybridize with
a, a, and S chain cDNA clones. In contrast, equivalent
amounts ofRNA from the IL2-dependent CTLL cells hy-
bridized to a (1.7-kb), /3 (1.3- and 1.1-kb), and y (1.5-kb)
chain cDNA probes, whileRNA from AS-9 suppressor T
cell hybridoma cells (11) hybridized to y (not shown) and
S (1.6-kb) chain cDNA probes. These results indicate that
only the TCR y gene, but not TCR a, /3, or S genes, is
transcribed in 11,3-dependent anti-self-specific suppressor cells.
The cells were further examined for rearrangement of the
TCR (3 and y genes by Southern blot analysis. Rearrange-
ment of the 01 gene complex was determined with thepHDS
22 probe (V97 + C02) and HindIII-digested DNA from
C3H liver cells, clones 11.7 and 11.12 cells, and CTLL cells
(Fig. 3 B, a) . Rearrangement of the y gene was determined
with the TCR y C region (Cy 2) probe (pHDS 4) and
EcoRI-digested DNA (Fig. 3 B, b) . Clones 11.7 and 11.12
showed no rearrangements ofTCR a and y gene clusters.
In contrast, CTLL cells showed both TCR /3 and y gene
rearrangements as previously reported (15) .
The phenotype of clone 11.7 was determined by im-
munofluorescence staining and flow cytometric analysis using
a panel ofmAbs. As shown in Fig. 4, clone 11.7 cells were
strongly positive for Thy-1 determinants, but had no detect-
able CD4 or CD8 T cell surface markers . Despite the pres-
ence ofTCR y gene transcript, clone 11.7 cells express nei-
ther cell surface CD3 nor TCR- ,y/S determinants. They do
not express IIr2R glycoproteins nor antigens associated with
B cells (Lyt-5) and macrophages (Mac 1) (data not shown) .
With regard to the expression ofMHC antigens, both clones
11.7 and 3.2 are positive for class I H-2Dk antigens, but
negative for class II antigens (I-Ak) (Fig . 5) . Expression of
H-2Kk was always much less than that of H-2Dk, and
ranged from 0 to 10% .
Discussion
The results described here demonstrate that continuous
culture of adult bone marrow in IL3 leads to development
of lymphoid cell populations capable of suppressing in vitro
as well as in vivo responses to self-MHC antigens. IL3,, which
is alsoknown as multilineage CSF (multi-CSF), supports the
growth and development of hematopoietic cells from every
Figure 3 .
￿
(A) Analysis ofTCR gene expression by Northern blotting. Total cellular RNA was isolated from bone marrow-derived, 11,3-
dependent clones 11 .7 and 11.12, 11r2-dependent CTLL cells, and a suppressor T cell hybridoma line, AS-9 . After electrophoresis through 1%
agarose gels, RNA blots were hybridized to 32P-labeled (2-5 x 108 cpm/Pg) TCR tx (a), 0 (b), y (c), and S (d) chain cDNA clones. Position
of rRNA markers are as indicated . (B) Analysis of TCR gene rearrangement by Southern blotting . Genomic DNA was isolated from the adult
OH mouse liver, clones 11 .7 and 11.12, and CTLL cells. (a) HindIII-digested DNA was subjected to electrophoresis on a 0.8% agarose gel and
hybridized to 32P-labeled TCR S probe. (b) EcoRl-digested DNA was hybridized with a TCR--y probe. Position of HindIII-cut X-size markers
are as indicated .
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￿
Two-color immunofluorescence analysis of Thy-1, CD3,
CD4, CD8, and TCR-.y/6 determinants on IL3-dependent bone
marrow-derived clone 11 .7 cells . The clone cells were stained with
FITC-conjugated antiThy-1 (30-H12) and anti-CD3 (2C11) anti-
bodies, biotin-conjugated anti-6 (3A10) antibodies, and streptavidin-
PE . The cells were also stained with anti-CD4 (GK1.5)-PE and anti-
CD8 (53-6.7)-FITC. Control cells consisted of thymocytes of a 1-wk-
old C57BL/6 mouse. Markers indicated by broken lines were settled
according to the negative controls incubated with streptavidin-PE and
affinity-purified goat anti-hamster IgG-FITC . Fluorescence intensities
are shown in logio scales.
major hemopoietic lineage in vitro and generates multi-lineage
colonies from bone marrow cells (26, 27) . There had been
no well-substantiated evidence that indicated that this cytokine
interacts with cells of a lymphoid lineage. Recently, how-
ever, Palacios et al . (28) demonstrated that IL3 is also capable
of differentiating early T progenitor cells from adult bone
marrow . They have established several cell clones (proT cells)
by in vitro culture ofbone marrow from CBA/N-nu/nu mice
in IL3 . ProT cells have low levels of Thy-1 and no detectable
Lyt-2 orL3T4 surface markers, express short RNA transcripts
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Figure 5 .
￿
Single-color immunofluorescence analysis of surface
MHC antigen expression. Clone 11.7 and 3.2 cells and C3H lymph
node cells were treated with mouse IgG (control), anti-H-2Kk (11-
4 .1), anti-H-213k (HB 24), and anti-I-Ak (11-5.2) antibodies. These
antibodies were stained with FITC-conjugated goat anti-mouse IgG .
(-1.0-1.2 kb) of the y gene, and no RNA transcripts of
either the a or the (3 genes. Their 6 gene transcription was
not examined . Upon repopulation into the thymus of sub-
lethally irradiated host mice, these cells give rise to pheno-
typically and functionally mature T cells .
It appears that bone marrow-derived suppressor clones,
represented by clone 11.7, are early T lymphocyte lineages
similar to the cells described by Palacios et al . (28) . Clone
11.7 cells have a high degree of Thy-1 expression but lack
other T cell markers such as L3T4 (CD4) and Lyt-2 (CD8) .
They express class I antigens but no class II antigens . The
reason for more expression of H-21)k antigen than H-2Kk
antigen is not immediately known . It could be nonspecific
suppression due to long-term culture, or specific suppression
through an event occurring in or near the genes controlling
H-2Kk antigen expression . While they do not have a cell
surfaceCD3/TCR complex, they express 1.5-kbRNA tran-
scripts of the TCR y gene. TCR cx, a, or 6 genes were not
transcribed in these cells . To our surprise, Southern blot analysis
revealed no TCR y gene rearrangement in these cells. Sig-
nificance ofTCR yRNA expression without TCR y gene
rearrangement is not immediately known . Recent reports by
Weinstein et al. (29) described expression ofhigh-levely gene
transcripts in Ilr3-dependent leukemia cell lines, suggesting
that IL3 may influence the ability of lymphoid/myeloid pro-
genitors to commit to the T cell lineage . Interestingly, like
clones 11.7 and 11.12 in our study, IL3-dependent leukemia
cells in Weinstein's study (29) showed no genomic y gene
rearrangement despite apparent full-size transcription of the
y gene. Transcription of TCR y gene was shown to be de-
pendent on the presence of IL3 because TCR y gene tran-scripts were lost in the absence of IL -3 and reappeared when
11,3 was added back. Although the TCR gene rearrangements
are thought to occur primarily in the thymus, extrathymic
y gene rearrangements have been reported. For example, y
gene rearrangement occurs in fetalliver (30), in bone marrow
culture in the presence of Con A-conditioned medium (31),
and in the long-term cultured bone marrow cells of athymic
nude mice (32).
What are the functions of these early extrathymic cellsex-
pressing the TCR 'y gene? While no function has been as-
signed to the cells described in the previous reports (28, 29,
32), present studies demonstrate that IL3-dependent, bone
marrow-derived, TCR y RNA-positive clones such as clone
11.7 are capable ofsuppressing the immune response directed
against their own MHC antigens; i.e., they function as veto
cells. When clone 11.7 cells were added to allogeneic MLC,
they inhibited CTL generationagainst their surface antigens
shared by stimulator cells. They had no effect in MLC ofthird-
party responder-stimulator combinations. In addition, adminis-
tration ofbone marrow-derived clones into immunosuppressed
recipients prolonged survival of skin allografts that shared
the same MHC antigens as those of the added cells. These
marrow-derived clones were not effective in prolonging third-
party skin allografts ofcomparable histoincompatibility (i.e.,
B10.AKM skin allografts in B6AF1 mice). The relatively
short prolongation observed in these experiments could be
attributed to too low an 11,3 dose (100-200 U/wk) and/or
inappropriate cell doses (2.5 x 107 cells/injection) used in
those experiments. Because these marrow-derived clones have
been in culture for a long period, it is possible that the majority
of injected cells may be trapped and destroyed in the reticuloen-
dothelial system before they exert their function. Further ex-
periments are in progress to determine the optimal dose
(numbers) and timing of IL3 and cells to achieve maximal
suppressive effect. Nevertheless, the present results suggest
that these immature cells may play an important role in the
induction of self-tolerance very early in T cell ontogeny.
While these cells might eventually home to the thymus
and differentiate into mature T cells, repeated attempts to
repopulate clone 11.7 cells (H-2k, Thy-1.2) in the thymus of
irradiated AKR mice (H-2k, Thy-1.1) have thus far failed.
Therefore, it is possible that these cells may represent a unique
population of immature lymphoid cells that remain in the
extrathymic environment. Suppression of anti-self immunity
by these cells could represent an alternative mechanism to
intrathymic elimination of self-reactive T cells (33-36) for
the induction of self-tolerance. These cells may remain dor-
mant in the bone marrow except when suppression of anti-
self-MHC reactivity is required during the early ontogeny
of T cell differentiation. In a bone marrow-induced allograft
unresponsiveness model (1), activation and proliferation of
these cells in donor marrow occur as a result of increased
production of 11,3 by the host T lymphocytes after alloan-
tigen stimulation.
What is the mechanism ofthe observed suppression ofCTL
generation by clone 11.7 cells? It is unlikely that suppression
is mediated by lysis of stimulator cells by these cloned cells.
Clone 11.7 lacked lyticactivity ofNC and NK cells, and failed
to lyse syngeneic H-2k targets (1,929 cells) in an 18-h assay.
Alternatively, the suppression by clone 11.7 cells may take
place through their recognition of receptors that can recog-
nize self-antigens, i.e., through recognition ofanti-self idio-
types. However, this is also unlikely because the bone
marrow-derived suppressor cells lack the conventional CD3/
TCR complex. Lack of TCR y gene rearrangement suggests
that the TCR y gene transcript is probably nonfunctional.
It cannot be ruled out, however, that the cells possess a unique
receptor for anti-self idiotypes that is yet to be identified.
A more likely possibility is, as has been suggested previously
(37, 38), that the alloreactive T cells bearing receptor to the
MHC antigen of stimulator cells recognize the same MHC
antigen on suppressor cells that in turn send out an inac-
tivating signal to the recognizing T cells. The final inactivating
signal couldbe an antigen-nonspecific soluble factor, whereas
the specificity of suppression is achieved through recogni-
tion of class I antigens that are expressed by the suppressor
cells. Similarly, in the case of self-tolerance induction, a self-
reactive cell, probably a T cytotoxic precursor cell, triggers
its own suppression by recognizing the class I MHC antigen
shared by the suppressor cell and itself (the self-reactive cell).
This hypothesis is supported by the in vitro experiments in
which significant suppression of CTL generation occurred
when stimulator cells possessed H-2Kk and/or H-21)k an-
tigens but not H-2 I-Ak and I-Ek antigens alone. Marked
suppression of anti-H-2Kk CTL generation by these sup-
pressor cells despite their low expression of H-2Kk antigens
needs further investigation. It could be that very low expres-
sion of class I MHC antigens is sufficient to induce suppres-
sion. Alternatively, suppression may be mediated through pos-
sible crossreactivity of anti-H-2Kk T cytotoxic precursor
cells with H-21)k determinants.
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